Table 1 Synopsis of the European Forum for TB Innovation series
Addressing and preventing resistance: rational use of new diagnostics and drug regimens
Addressing TB prevention: is LTBI a programmatic component?
Community and patient participation in TB control, care and cure: from incidental activity to structural involvement
Moving from hospital to community TB care: challenges and opportunities for high-burden MDR-TB countries
  • TB: tuberculosis; LTBI: latent tuberculosis infection; MDR: multidrug-resistant.